Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, 60 Fenwood Road, BTM 6022, Boston, MA, 02115, USA.
Harvard Medical School, Boston, MA, 02115, USA.
Calcif Tissue Int. 2018 Apr;102(4):406-414. doi: 10.1007/s00223-018-0395-3. Epub 2018 Jan 23.
Microbiota and their hosts have coevolved for millions of years. Microbiota are not only critical for optimal development of the host under normal physiological growth, but also important to ensure proper host development during nutrient scarcity or disease conditions. A large body of research has begun to detail the mechanism(s) of how microbiota cooperate with the host to maintain optimal health status. One crucial host pathway recently demonstrated to be modulated by microbiota is that of the growth factor insulin like growth factor 1 (IGF-1). Gut microbiota are capable of dynamically modulating circulating IGF-1 in the host, with the majority of data suggesting that microbiota induce host IGF-1 synthesis to influence growth. Microbiota-derived metabolites such as short chain fatty acids are sufficient to induce IGF-1. Whether microbiota induction of IGF-1 is mediated by the difference in growth hormone expression or the host sensitivity to growth hormone is still under investigation. This review summarizes the current data detailing the interaction between gut microbiota, IGF-1 and host development.
微生物组及其宿主已经共同进化了数百万年。微生物组不仅对宿主在正常生理生长下的最佳发育至关重要,而且在营养匮乏或疾病条件下,确保宿主的正常发育也很重要。大量的研究开始详细阐述微生物组与宿主合作维持最佳健康状态的机制。最近发现的一个关键宿主途径是生长因子胰岛素样生长因子 1(IGF-1)。肠道微生物组能够在宿主中动态调节循环中的 IGF-1,大多数数据表明,微生物组诱导宿主 IGF-1 合成以影响生长。微生物组衍生的代谢物,如短链脂肪酸,足以诱导 IGF-1。微生物组诱导 IGF-1 是否是通过生长激素表达的差异或宿主对生长激素的敏感性来介导的,仍在研究中。本综述总结了目前详细描述肠道微生物组、IGF-1 和宿主发育之间相互作用的研究数据。